Home/Adial Pharmaceuticals/Brigitte Robertson, MD
BR

Brigitte Robertson, MD

Acting Chief Medical Officer

Adial Pharmaceuticals

Adial Pharmaceuticals Pipeline

DrugIndicationPhase
AD04Alcohol Use Disorder (AUD) in genetically targeted patientsPhase 3